Log In
BCIQ
Print this Print this
 

farletuzumab (MORAb-003)

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionHumanized IgG1 antibody targeting the folate receptor 1 (FOLR1; FR-alpha)
Molecular Target Folate receptor 1 (FOLR1) (FR-alpha)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/17/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today